Alain Wille
Wille brings more than 25 years of animal health industry experience, including leadership positions at Boehringer Ingelheim and Merial. Animab was founded in June 2020 and raised EUR 3.4 million in seed funding from V-Bio Ventures and QBIC. Its lead product Nanoprotec is an oral monoclonal antibody targeting post-weaning diarrhea in piglets caused by E. coli (ETEC). In July 2025 the company closed a EUR 10 million Series B to support a regulatory submission to the European Medicines Agency and a projected market launch by end of 2026.
Career
Roles
AnimabChief Executive OfficerJun 2020 – Present
- Boehringer IngelheimHead of Strategic Business Unit SwineJan 2017 – May 2020
- Boehringer IngelheimHead of Global Marketing Poultry VaccinesJul 2011 – Dec 2016
- MerialHead of Global Strategic Marketing Avian and SwineAug 2006 – May 2011
- MerialCountry manager BeneluxAug 2005 – Jul 2006
- MerialHead of Global strategic Marketing EquineAug 2003 – Jul 2005
- MerialCountry Manager Head of Companion Animal EnterpriseJan 2000 – Jul 2003
- MerialMarketing Director Companion Animal PharmaceuticalsNov 1998 – Dec 1999
- Fort Dodge Animal HealthBusiness Unit Manager Avian BeneluxNov 1994 – Oct 1998
Education
- RU GhentDVM, Veterinary Medecine1981 - 1987
- KA Voskeslaan
From public career histories · 11 entries